SAR 157.4
(-0.51%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 249.83 Million SAR | 30.43% |
2022 | 191.55 Million SAR | -4.54% |
2021 | 200.65 Million SAR | -36.62% |
2020 | 316.59 Million SAR | 47.86% |
2019 | 214.11 Million SAR | 3.2% |
2018 | 207.48 Million SAR | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 299.4 Million SAR | 19.84% |
2024 Q2 | 351.43 Million SAR | 17.38% |
2023 FY | 249.83 Million SAR | 30.43% |
2023 Q3 | 297.55 Million SAR | 11.77% |
2023 Q1 | 222.45 Million SAR | 16.13% |
2023 Q4 | 249.83 Million SAR | -16.04% |
2023 Q2 | 266.22 Million SAR | 19.68% |
2022 Q1 | - SAR | -100.0% |
2022 Q4 | 191.55 Million SAR | 0.0% |
2022 FY | 191.55 Million SAR | -4.54% |
2022 Q2 | 245.57 Million SAR | 0.0% |
2021 Q1 | - SAR | 0.0% |
2021 FY | 200.65 Million SAR | -36.62% |
2021 Q4 | 200.65 Million SAR | 0.0% |
2021 Q3 | 200.65 Million SAR | 0.0% |
2020 FY | 316.59 Million SAR | 47.86% |
2019 FY | 214.11 Million SAR | 3.2% |
2018 FY | 207.48 Million SAR | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
Saudi Pharmaceutical Industries and Medical Appliances Corporation | 2.35 Billion SAR | 89.396% |